UK markets closed

Agilent Technologies, Inc. (A)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
137.69-1.90 (-1.36%)
As of 12:54PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close139.59
Open138.60
Bid137.78 x 1000
Ask137.84 x 800
Day's range137.58 - 139.59
52-week range96.80 - 151.58
Volume222,661
Avg. volume1,583,904
Market cap40.351B
Beta (5Y monthly)1.12
PE ratio (TTM)33.02
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield0.94 (0.68%)
Ex-dividend date01 Apr 2024
1y target estN/A
  • Business Wire

    Agilent Names Simon May to Lead Diagnostics and Genomics Group

    SANTA CLARA, Calif., April 29, 2024--Agilent Technologies, Inc. (NYSE: A) today announced Simon May has been named president of the company’s Diagnostics and Genomics Group (DGG). May, previously executive vice president and president of the Life Science Group at Bio-Rad Laboratories, will join Agilent on May 6.

  • Business Wire

    Agilent Receives Scientists' Choice Awards for Sustainability

    SANTA CLARA, Calif., April 16, 2024--Agilent Technologies Inc. (NYSE: A) announces that it is the recipient of two 2023 Sustainability Scientists’ Choice awards — Sustainable Supplier of the Year and Sustainable Product of the Year. These awards recognize Agilent as a leader in the area of sustainability.

  • Business Wire

    Agilent Receives European IVDR Class C Certification for GenetiSure Dx Postnatal Assay

    SANTA CLARA, Calif., April 15, 2024--Agilent Technologies Inc. (NYSE: A) today announced that its GenetiSure Dx Postnatal Assay has received European IVDR Class C Certification. This certification demonstrates that the assay meets the higher standards established by IVDR. It ensures the continued availability of this trusted qualitative assay to clinical geneticists and other healthcare professionals throughout the EU.